BamSEC and AlphaSense Join Forces
Learn More

Nektar Therapeutics

NASDAQ: NKTR    
Share price (8/4/25): $23.27    
Market cap (8/4/25): $289 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 44 pages 4,255,320 Shares of Common Stock Nektar Therapeutics Underwriting Agreement
12/34/56
EX-1.2
from S-3 44 pages Nektar Therapeutics Equity Distribution Agreement
12/34/56
EX-1
from SCHEDULE 13G/A 1 page Whereas, in Accordance With Rule 13d-1(k)(1) Under the Securities and Exchange Act of 1934 (The "Act"), Only One Joint Statement and Any Amendments Thereto Need to Be Filed Whenever One or More Persons Are Required to File Such a Statement or Any Amendments Thereto Pursuant to Section 13(d) of the Act With Respect to the Same Securities, Provided That Said Persons Agree in Writing That Such Statement or Amendments Thereto Is Filed on Behalf of Each of Them; Now, Therefore, the Parties Hereto Agree as Follows
12/34/56
EX-1.1
from 8-K 79 pages Asset Purchase Agreement by and Between Nektar Therapeutics and [* * *] Dated as of November 1, 2024
12/34/56
EX-1.2
from S-3ASR 44 pages Nektar Therapeutics Common Stock Sales Agreement
12/34/56
EX-1.1
from 8-K 37 pages Nektar Therapeutics 13,000,000 Shares of Common Stock, $0.0001 Par Value Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages Nektar Therapeutics 8,500,000 Shares of Common Stock, $0.0001 Par Value Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 38 pages 19,000,000 Shares Nektar Therapeutics Common Stock ($0.0001 Par Value Per Share) Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Joint Acquisition Statement
12/34/56
EX-1.1
from 8-K 23 pages Common Stock Purchase Agreement Dated as of August 15, 2005 by and Between Nektar Therapeutics and Mainfield Enterprises, Inc
12/34/56
EX-1
from SC 13G/A 1 page Joint Acquisition Statement
12/34/56
EX-1
from SC 13G/A 1 page <page> <table> <caption> Exhibit 1 <s> <c> Identification of the Subsidiaries Which Acquired Securities Smith Barney Fund Management LLC and Salomon Brothers Asset Management Inc Each an Investment Advisor in Accordance With Section 240.13d-1(b) (1)(ii)(e) the Undersigned Hereby Affirms the Identification of the Subsidiaries Which Acquired the Securities Reported in This Schedule 13g. Date: May 10, 2004 Citigroup Inc. By: /S/ Serena D. Moe Name: Serena D. Moe Title: Assistant Secretary </Table>
12/34/56
EX-1.1
from 8-K 43 pages Nektar Therapeutics (A Delaware Corporation) 9,500,000 Shares of Common Stock Underwriting Agreement Dated: March 8, 2004
12/34/56
EX-1
from SC 13G/A 1 page Joint Acquisition Statement
12/34/56
EX-1
from SC 13G/A 1 page Joint Acquisition Statement
12/34/56
EX-1
from SC 13G/A ~1 page Joint Acquisition Statement
12/34/56
EX-1
from SC 13G/A ~1 page Joint Acquisition Statement
12/34/56
EX-1
from SC 13G ~1 page Joint Acquisitions
12/34/56
EX-1.1
from S-3/A ~20 pages Underwriting agreement
12/34/56